Conditions:  Stage IIIC Fallopian Tube Cancer;  Stage IIIC Ovarian Cancer;  Stage IIIC Primary Peritoneal Cancer;  Stage IV Fallopian Tube Cancer;  Stage IV Ovarian Cancer;  Stage IV Primary Peritoneal Cancer
Interventions:  Drug: Carboplatin;  Other: Quality-of-Life Assessment;  Other: Questionnaire Administration;  Procedure: Cytoreductive Surgery
Sponsors:  Wake Forest University Health Sciences;  National Cancer Institute (NCI)
**RECRUITING NOW**
Interventions:  Drug: Carboplatin;  Other: Quality-of-Life Assessment;  Other: Questionnaire Administration;  Procedure: Cytoreductive Surgery
Sponsors:  Wake Forest University Health Sciences;  National Cancer Institute (NCI)
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
